EULAR Issues Imaging Recommendations for Gout, CPPD
The document provides guidance on using imaging in the diagnosis and management of all common forms of crystal-induced arthropathies.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The document provides guidance on using imaging in the diagnosis and management of all common forms of crystal-induced arthropathies.
The update builds on 2019 recommendations and incorporates safety concerns about JAK inhibitors, advises on differential drug efficacy across disease manifestations, and eliminates systemic steroids.
Three studies provide more data on risk for major adverse cardiovascular events with JAK inhibitors vs TNF inhibitors, as well as their efficacy in patients with different levels of risk.
Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid
Patients with rheumatoid arthritis who take a tumor necrosis factor inhibitor do not appear to have a consistent and significant risk for developing a demyelinating disease.